Vertex Pharmaceuticals VRTX has outperformed the market over the past 15 years by 5.86% on an annualized basis producing an average annual return of 17.7%. Currently, Vertex Pharmaceuticals has a ...

Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) has recently achieved a significant milestone with the FDA's approval of JOURNAVX(suzetrigine), a novel non-opioid pain medication. This approval marks ...

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Vertex Inc (VERX) reports robust revenue growth and strategic investments in AI and e-invoicing, setting the stage for future expansion despite margin pressures. The headline numbers for Vertex ...

Their ultimate uptake, however, remains to be seen. When Vertex Pharmaceuticals won FDA approval for Journavx last month, it opened a new era in a therapeutic space recently fraught with suffering, ...

Robert F. Kennedy Jr. speaks in the Oval Office of the White House next to U.S. President Donald Trump and U.S. Representative Marjorie Taylor Greene (R-GA), on the day Kennedy is sworn in as ...

Healthcare & Pharmaceuticalscategory· February 21, 2025 Teva Pharma and Alvotech launch biosimilar to J&J's Stelara in US Teva Pharmaceuticals ... a strong dollar and a sharp drop in sales ...